IRIS
CONSOLI, Agostino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.902
EU - Europa 6.186
AS - Asia 3.396
AF - Africa 25
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 4
Totale 16.548
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.875
CN - Cina 1.349
UA - Ucraina 1.178
IE - Irlanda 1.117
TR - Turchia 908
SG - Singapore 838
IT - Italia 795
SE - Svezia 748
GB - Regno Unito 692
FR - Francia 672
DE - Germania 405
FI - Finlandia 241
IN - India 226
RU - Federazione Russa 213
CZ - Repubblica Ceca 28
BE - Belgio 24
CA - Canada 23
VN - Vietnam 23
EG - Egitto 17
EU - Europa 16
NL - Olanda 16
PL - Polonia 16
KR - Corea 12
IL - Israele 10
ES - Italia 9
RO - Romania 9
BR - Brasile 6
AR - Argentina 5
BG - Bulgaria 5
JP - Giappone 5
TW - Taiwan 5
IR - Iran 4
PE - Perù 4
AT - Austria 3
AU - Australia 3
BD - Bangladesh 3
GR - Grecia 3
MY - Malesia 3
PK - Pakistan 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
DK - Danimarca 2
ET - Etiopia 2
HK - Hong Kong 2
MX - Messico 2
PT - Portogallo 2
SC - Seychelles 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BJ - Benin 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
LI - Liechtenstein 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
UY - Uruguay 1
VE - Venezuela 1
Totale 16.548
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.356
Chandler 1.297
Dublin 1.112
Singapore 707
Southend 556
Princeton 538
Izmir 498
Nanjing 383
Dearborn 376
Ashburn 267
Wilmington 252
Cambridge 221
Beijing 209
Santa Clara 150
Nanchang 148
Ann Arbor 145
Altamura 140
Boardman 114
Shenyang 98
Chieti 94
Woodbridge 91
Los Angeles 90
Hebei 68
Kunming 64
Grevenbroich 61
Tianjin 59
Jiaxing 56
Norwalk 52
Washington 50
Rome 43
Moscow 36
New York 33
Changsha 32
Ningbo 32
Pescara 31
Hangzhou 30
Helsinki 29
Cedar Knolls 28
Milan 28
Falls Church 27
Orange 27
Houston 25
Munich 24
Dong Ket 23
Jinan 23
Brno 22
Brussels 20
San Mateo 19
Guangzhou 18
Changchun 16
Hefei 16
Leawood 16
Toronto 15
Augusta 14
Lanzhou 13
Zhengzhou 13
Auburn Hills 12
Alexandria 11
Kocaeli 11
London 11
Seattle 11
Naples 10
Taizhou 10
Guardiagrele 9
Kraków 9
Palermo 9
Viterbo 9
Wŏnju 9
Florence 8
Simi Valley 8
San Vito Chietino 7
Shanghai 7
Tappahannock 7
Madrid 6
Romola 6
Bialystok 5
Chengdu 5
Chicago 5
Düsseldorf 5
Frankfurt am Main 5
Fuzhou 5
Lissone 5
Mountain View 5
Mumbai 5
Ottawa 5
Perugia 5
Pianella 5
Trieste 5
Bari 4
Bellante 4
Brusciano 4
Città Di Castello 4
Dordrecht 4
Edinburgh 4
Haikou 4
L'aquila 4
Lanciano 4
Livorno 4
L’Aquila 4
Tokyo 4
Totale 10.188
Salva come PNG Salva come JPEG
Nome #
Vitamin E supplementation normalizes LDL susceptibility to oxidation in well controlled uncomplicated type II diabetes mellitus 138
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 124
Adherence of Uremic Erythrocytes to Vascular Endothelium decreases Endothelial Nitric Oxide Synthase Expression 121
Obesity modifies the effects of the Asp905Tyr variant of PPP1R3A on risk of type 2 diabetes and insulin sensitivity 118
Il trattamento con Metformina riduce i livelli di alcuni indicatori di stress ossidativi in diabetici di tipo 2 115
Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial. 115
Principi di Endocrinologia 112
A comparative safety review between GLP-1 receptor agonists and SGLT2 inhibitors for diabetes treatment 112
Centella Asiatica inhibits TNFα-induced adhesion molecule expression in endothelial cells of umbilical cords from gestational diabetic women. 111
Preliminari esperienze terapeutiche del diabete in gravidanza 108
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 107
Mechanisms of uremic erytrocyte-induced adhesion of human monocytes to cultured endothelial cells 105
Relationship between patient-practice oriented knowledge and metabolic control in intensively treated Type 1 diabetic patient: Result of the validation of the knowledge and Practices Diabetes Questionnaire 105
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 103
Transmural distribution of antioxidant defences and lipid peroxidation in the rabbit left ventricular myocardium 101
Insulin enhances vascular adhesion molecule (VCAM-1) expression in human cultured endothelial cells through a pro-atherogenic p38MAP-kinase mediated pathway. 99
Endocrinologia Clinica 98
Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: association with increased nitric oxide synthase expression and superoxide anion generation. 98
ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1678-83. 98
TRIB3 R84 variant is associated with impaired insulin-mediated nitric oxide production in human endothelial cells. 97
Heightened free radical activity in angina pectoris 97
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 96
Policaptil Gel Retard® reduces body weight and improves insulin sensitivity in obese subjects 95
Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus? 95
Features of endothelial dysfunction in umbilical cord vessels of women with gestational diabetes 92
DHEA mimics acute actions of insulin to stimulate production of both NO and ET-1 via distinct PI 3-kinase- and MAP-kinase-dependent pathways in vascular endothelium. 92
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) regulates endothelial nitric oxide synthase (eNOS) activity and its localization within the human vein endothelial cells (HUVEC) in culture. 91
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 91
Combined effect of glucose and insulin in stimulating plasminogen activator inhibitor-1 secretion and gene expression in human vascular smooth muscle cells in culture 90
Valutazione del fabbisogno insulinico post-prandiale in pazienti diabetici trattati con microinfusore insulinico 89
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences 89
[Type 2 diabetes treatment and cardiovascular risk: what can we learn from trials?] 89
Phenylmethimazole reverses plasminogen activator inhibitor-1 (PAI-1) overexpression in diabetic rats 88
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 88
Chronic in vivo hyperglycaemia increases nitroxidant stress and hinders nitric oxide availability in human vessels and human endothelial cells 87
Plasminogen Activator Inhibitor-1 synthesis is increased in arterial wall of diabetic subjects 86
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 86
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects. 85
Treatment of brittle diabetes by continuous subcutaneous in-insulin infusion. Comparison with conventional treatment 85
Variations in carbohydrate, lipid and protein oxidation evaluated by indirect calorimetry in obese subjects on a "single-meal" low-calorie diet. 85
Liraglutide and cardiovascular outcomes in type 2 diabetes 85
Inositol and antioxidant supplementation: Safety and efficacy in pregnancy 85
Iperespressione dell'inibitore dell'attivatore del plasminogeno di tipo 1 (PAI-1) nel fegato e nella aorta di ratti diabetici 84
Selective insulin resistance affecting nitric oxide release but nor plasminogen activator inhibitor-1 synthesis in fibroblast from insulin-resistant individuals. 84
I glitazoni 84
Arterial wall and liver of diabetic rats exhibit increased synthesis of plasminogen activator inhibitor-1 (PAI-1). 83
Treatment of unstable diabetes by continuous subcutaneous infusion of insulin. 83
MicroRNA profiling reveals new potential modulators of insulin-resistance and cardiovascular risk in type 2 diabetes 83
Distribuzione transmurale dei sistemi antiossidanti e della perossidazione lipidica nel ventricolo sinistro di coniglio 83
Synergic effect of glucose and insulin in stimulating plasminogen activator inhibitor 1 (PAI-1) expression and secretion in human vascular smooth cells (vSMC) 82
I livelli di inibitore dell’attivatore del plasminogeno-1 (PAI-1) risultano aumentati nella parete arteriosa di pazienti diabetici 82
Decreased expression of the plasminogen activator inhibitor-1 (PAI-1) gene in diabetic rats treated with phenylmethimazole 82
The TRIB3 R84 variant is associated with increased carotid intima-media thickness in vivo and with enhanced MAPK signalling in human endothelial cells. 82
La terapia insulinica: tradizione e novità 82
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity 82
Cigarette smoke, ferritin, and lipid peroxidation 82
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control 82
Blood sugar control in diabetic patients bearing microinfusors: the importance of the dawn phenomenon 81
Transcriptome analysis of human primary endothelial cells (HUVEC) from umbilical cords of Gestational Diabetic mothers reveals candidate sites for an epigenetic modulation of specific gene expression. 81
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 81
Acute hyperglycemia and acute hyperinsulinemia both decrease plasma fibrinolytic activity and increase plasminogen activator type-1 (PAI-1) in the rat. 80
Thromboxane-dependent platelet activation in obese subjects with prediabetes or early type 2 diabetes: Effects of liraglutide-or lifestyle changes-induced weight loss 80
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 79
The dawn phenomenon in Type I (insulin-dependent) diabetic patient treated by continuous subcutaneous insulin infusion. 79
MicroRNA profiling reveals new potential modulators of insulin-resistance in type 2 Diabetes 79
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 78
The C242T polymorphism of the p22phox component of NAD(P)H oxidase and vascular risk. Two case-control studies and a meta-analysis. 78
Effects of a "single-meal" low calorie diet on the circadian variation of serum cortisol, insulin and somatotropin and urinary excretion of catecholamines. 78
Liraglutide mitigates TNF-alfa induced pro-atherogenic changes and microvesicle release in HUVEC from diabetic women 78
Ottimizzazione della terapia con insulina basale nel DM2: add-on di GLP-1 RA in associazione libera e in combinazione pre-costituita 78
Ruolo del fegato 77
Increased Plasminogen Activator Inhibitor (PAI-1) Synthesis and Gene Expression in Adipocyte of Diabetic Rats 77
G972R IRS-1 variant impairs insulin regulation of eNOS in cultured human endothelial cells 77
Valutazione dell’efficacia delle prestazioni nel servizio di diabetologia: impatto dell’emoglobina glicata 77
La dieta ipocalorica nella terapia del diabete di tipo 2 con obesità. Confronto con dieta ipo- e normoglicidica a differente contenuto calorico. 77
Assorbimento dell’insulina umana semisintetica dopo iniezione sottocutanea a spruzzo transcutaneo mediante iniettore 77
Soluble RAGE in type 2 diabetes: association with oxidative stress. 76
The prominent role of p38 mitogen-activated protein kinase in insulin-mediated enhancement of VCAM-1 expression in endothelial cells. 76
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 76
MicroRNA profiling reveals new potetial modulators of insulin resistance and cardiovascular risk in type 2 diabetes 76
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance. 76
Semaglutide and cardiovascular outcomes in patients with type 2 diabetes 76
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. 75
Iperespressione dell’inibitore dell’attivatore del plasminogeno di tipo 1 (PAI-1) nel fegato e nell’aorta di ratti diabetici 75
Can the glucose load test predict insulin requirement in gestational diabetes with normal fasting blood glucose (Type B)?. 75
Il sintomo impotenza come esordio di una neuropatia diabetica nel paziente di sesso maschile 74
Deletion of Gly723 in the insulin receptor substrate-1 of a patient with noninsulin-dependent diabetes mellitus. 74
Plasminogen activator inhibitor type 1 is increased in the arterial wall of type 2 diabetic subjects 73
Both acute and chronic hyperglycemia decrease plasma fribrinolytic activity in the rat. 73
Protective effects of glucagon-like peptide-1 on beta-cells: preclinical and clinical data. 72
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 72
Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals 72
L’impatto socio-economico delle ipoglicemie 72
Potential side effects to GLP-1 agonists: Understanding their safety and tolerability 72
Phenotyping normal kidney function in elderly patients with type 2 diabetes: a cross-sectional multicentre study 72
Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in culture. 72
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity. 72
Short term vitamin E treatment normalizes LDL oxidative susceptibility in diabetic subjects 71
Determinanti del controllo metabolico in pazienti con diabete di tipo I in terapia insulinica intensiva 71
Interrelazione fra variazioni della glicoemoglobina e variazioni della massa corporea in diabetici di tipo 2 all’esordio seguiti per 6 anni. 71
Totale 8.647
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.337
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.337
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.211 0 0 0 103 285 287 414 351 108 321 321 21
2020/20211.525 237 14 261 29 127 335 42 35 123 222 30 70
2021/20221.200 29 33 2 247 93 19 50 79 107 36 157 348
2022/20233.707 325 403 196 435 324 758 233 288 493 54 116 82
2023/20241.883 111 61 135 69 74 497 474 78 26 79 63 216
2024/20251.575 336 694 507 38 0 0 0 0 0 0 0 0
Totale 17.475